Ziprasidone good value for schizophrenia exacerbations
Hopeful prognosis for neglected tropical diseases
NCCN updates renal, cervical cancer guidelines
Peginterferon-α-2a well worth it for chronic hepatitis B
Reduction of antibacterial duration plausible in neonatal infections
Indirect costs and benefits of adjuvant trastuzumab evaluated
Serious NSAID-related GI ulcer complications* are associated with direct annual costs of more than euro42 750 000 in The Netherlands,
Lower indirect costs a drawcard for XELOX vs FOLFOX-4
ICU care is cost effective in the UK
Sexual abstinence programmes ineffective in high income countries
News from IHEA
Guidelines, feedback effectively alter GP prescription patterns
Typical antipsychotics of greater benefit than atypicals
Montelukast reduces resource use in asthma/SAR
Lack of on-call coverage affects hospital finances and the delivery of healthcare services,
The multidisciplinary disease management of chronic heart failure (CHF) is effective in a heterogeneous Asian community-based setting,
Utility reduced with RA and AS but costs higher with RA
Underinsured children falling through the gaps in the US
Influenza virus vaccination coverage is very low in Spanish children,
High immunisation rates are achieved in infants, despite numerous misperceptions among parents about influenza infection and vaccination,
Flu vax subsidy worth it for elderly in Japan
New hope for HIV diagnostic tests in resource limited settings
Roflumilast of value in very severe COPD
Screen-and-treat osteoporosis strategy worth it for elderly men?
Rapid HIV testing, streamlined counselling well worth it
Rapid-recovery sedatives of benefit in colonoscopy
Skin cancer costly for renal transplant recipients
Antiretroviral costs halved after first year in South Africa
Aboriginal opioid injection drug users have a reduced likelihood of methadone use, compared with non-Aboriginal drug users,
News from ISTH
CTC with 6mm lesion threshold cost effective for CRC screening
Levosimendan pumps up QOL in advanced CHF
Carvedilol increases HRQOL in patients with MI
COPD: QOL boost during admission only temporary
Apotex has received support from two pharmaceutical companies to manufacture generic fixed-dose combination antiretroviral medicines in Canada,
The UK government wants to implement a value-based pricing system for drugs,
Novartis has failed in its legal challenge of a portion of India's Patent Act that restricts certain kinds of patents,
Judgement in favour of NICE Alzheimer's recommendations